A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.

Clinical trial NCT02326194 · COMPLETED

Trial details

NCT number: NCT02326194
Sponsor: Jiangsu Province Centers for Disease Control and Prevention
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ebola Virus Disease

Start date: 2014-12-01
Primary completion: 2015-02-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.